Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
HIMS
Hims & Hers Health I
$56.56
Chart
$25.84 (+118.89%)
$35.95 (+57.33%)
$30.89 (+83.10%)
$23.75 (+138.15%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
HIMS
Hims & Hers Health I
Current Price
$56.56
Login to view Hims & Hers Health I (HIMS) recommendation from the last 90 days from financial news and social media.
Chart
$25.84 (+118.89%)
$35.95 (+57.33%)
$30.89 (+83.10%)
$23.75 (+138.15%)
HIMS Latest Headlines
Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer. HIMS launches six-month Wegovy access at $549/month aiming to expand affordable obesity care with holistic weight loss solutions.
Wed May 28, 2025
Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer. HIMS launches six-month Wegovy access at $549/month aiming to expand affordable obesity care with holistic weight loss solutions.
Wed May 28, 2025
Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer. HIMS launches six-month Wegovy access at $549/month aiming to expand affordable obesity care with holistic weight loss solutions.
Wed May 28, 2025
Unpacking the Latest Options Trading Trends in Hims & Hers Health. Whales with a lot of money to spend have taken a noticeably bearish stance on Looking at options history for Hims &. Hers Health (NYSE:) we detected 9 trades.If we consider the specifics of each trade it is accurate to state that 33% of the investors opened trades with ish expectations and 44% with bearish.From the overall spotted trades 3 are puts for a total amount of $86127 and 6 calls for a total amount of $230135.Taking i
Wed May 28, 2025
Hims & Hers Health Stock Is Tumbling Thursday: Whats Happening?. ) is facing heavy selling pressure Thursday morning as the United States Food and Drug Administration’.s (FDA)ban of compounded drugs with in compounded drugs by outsourcing facilitiesas the agency’.s grace period comes to a close on Thursday. Hims &. Hers Health shares are under pressure as the firm sells cheaper versions of popular weight-loss drugs known as compounded drugs. Regulators allow compounded versions of
Thu May 22, 2025
Hims & Hers Health Stock Is Tumbling Thursday: Whats Happening?. ) is facing heavy selling pressure Thursday morning as the United States Food and Drug Administration’.s (FDA)ban of compounded drugs with in compounded drugs by outsourcing facilitiesas the agency’.s grace period comes to a close on Thursday. Hims &. Hers Health shares are under pressure as the firm sells cheaper versions of popular weight-loss drugs known as compounded drugs. Regulators allow compounded versions of
Thu May 22, 2025
Hims & Hers: After A Bout Of Uncertainty Upside Remains.
Wed May 21, 2025
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?. HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However macro challenges may hurt performance.
Fri May 16, 2025
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?. HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However macro challenges may hurt performance.
Fri May 16, 2025
Hims & Hers Stock Pulls Back After Strong Q1 Earnings 115% Gain Over Past Month. ) shares fell 3.09% Wednesday morning to $62.02 giving back some of the recent gains following its strong first-quarter earnings report.Despite the pullback the stock remains up an impressive 115% over the past month as investor enthusiasm around the company'.s growth story continues. first-quarter revenue of $586 million a 111% increase year over year and well above Wall Street expectations.Earnings per share c
Wed May 14, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HIMS Stock trends
HIMS Stock performance
HIMS Stock analysis
HIMS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
